Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Long-term treatment with linezolid in a patient with osteomyelitis undergoing hemodialysis

Núria Berenguer, Olivia Ferrández, Francesc Barbosa, Olatz Urbina, Merçè Espona, Santiago Grau

Producción científica: Contribución a una revistaArtículoInvestigaciónrevisión exhaustiva

Resumen

Anemia and/or thrombocytopenia are the most relevant adverse effects of linezolid treatment. We report the case of a patient under hemodialysis who developed osteomyelitis involving the amputation stump of the left limb due to a vancomycin-resistant and teicoplanin-resistant Enterococcus faecium successfully treated with linezolid for 6 months. Close monitorization of the patient probably contributed to maintenance of treatment with linezolid despite hematological alterations observed, which could be attributed to either the underlying patient's clinical condition or antimicrobial treatment. ©2012 Edizioni Scientifiche per l'Informazione su Farmaci e Terapia.
Idioma originalInglés
Páginas (desde-hasta)226-228
PublicaciónJournal of Chemotherapy
Volumen24
N.º4
DOI
EstadoPublicada - 1 ago 2012

Huella

Profundice en los temas de investigación de 'Long-term treatment with linezolid in a patient with osteomyelitis undergoing hemodialysis'. En conjunto forman una huella única.

Citar esto